ProfileGDS4718 / 222059_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 38% 42% 40% 43% 40% 33% 34% 42% 46% 43% 37% 41% 35% 31% 35% 38% 37% 39% 38% 54% 39% 35% 43% 43% 36% 33% 42% 34% 41% 36% 35% 27% 42% 42% 29% 37% 35% 42% 43% 29% 44% 37% 31% 30% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.8914838
GSM549102patient 115, normal, homogenized [OPG study]5.094342
GSM549104patient 119, normal, homogenized [OPG study]4.9929940
GSM549108patient 138, normal, homogenized [OPG study]5.1879943
GSM549119patient 077, normal, homogenized [OPG study]4.980140
GSM549133patient 032, cancer, homogenized [OPG study]4.6086433
GSM549139patient 042, cancer, homogenized [OPG study]4.7148734
GSM549099patient 107, normal, homogenized [OPG study]5.0952742
GSM549109patient 139, normal, homogenized [OPG study]5.3344346
GSM549110patient 046, normal, homogenized [OPG study]5.1493743
GSM549114patient 063, normal, homogenized [OPG study]4.7975737
GSM549122patient 082, normal, homogenized [OPG study]5.0345741
GSM549134patient 033, cancer, homogenized [OPG study]4.7317835
GSM549136patient 036, cancer, homogenized [OPG study]4.5415331
GSM549140patient 044, cancer, homogenized [OPG study]4.7054735
GSM549111patient 047, normal, homogenized [OPG study]4.8881538
GSM549113patient 057, normal, homogenized [OPG study]4.7721437
GSM549132patient 031, cancer, homogenized [OPG study]4.9036739
GSM549137patient 038, cancer, homogenized [OPG study]4.8487838
GSM549142patient 047, cancer, homogenized [OPG study]5.8903654
GSM549100patient 110, normal, homogenized [OPG study]4.9784339
GSM549107patient 135, normal, homogenized [OPG study]4.7159335
GSM549115patient 068, normal, homogenized [OPG study]5.0969843
GSM549116patient 072, normal, homogenized [OPG study]5.1152343
GSM549120patient 078, normal, homogenized [OPG study]4.8120236
GSM549131patient 030, cancer, homogenized [OPG study]4.6173833
GSM549118patient 074, normal, homogenized [OPG study]5.0740542
GSM549129patient 027, cancer, homogenized [OPG study]4.7178534
GSM549123patient 088, normal, homogenized [OPG study]5.005541
GSM549124patient 006, cancer, homogenized [OPG study]4.8355336
GSM549126patient 015, cancer, homogenized [OPG study]4.7285735
GSM549128patient 025, cancer, homogenized [OPG study]4.4048227
GSM549103patient 117, normal, homogenized [OPG study]5.1588742
GSM549117patient 073, normal, homogenized [OPG study]5.0514542
GSM549138patient 041, cancer, homogenized [OPG study]4.46429
GSM549141patient 045, cancer, homogenized [OPG study]4.7785337
GSM549130patient 028, cancer, homogenized [OPG study]4.7821235
GSM549101patient 111, normal, homogenized [OPG study]5.1400342
GSM549105patient 128, normal, homogenized [OPG study]5.1809743
GSM549106patient 134, normal, homogenized [OPG study]4.4296529
GSM549112patient 048, normal, homogenized [OPG study]5.2076944
GSM549125patient 011, cancer, homogenized [OPG study]4.8467437
GSM549127patient 024, cancer, homogenized [OPG study]4.57831
GSM549135patient 035, cancer, homogenized [OPG study]4.5123730